Mar 01, 2022 / 09:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Recro Fourth Quarter and Year-end 2021 Financial Results Conference Call. (Operator Instructions)
As a reminder, this conference call may be recorded. I would now like to hand the conference over to Stephanie Diaz of Recro's Investor Relations Group. Please go ahead.
Stephanie C. Diaz - Vida Strategic Partners Inc. - President & CEO
Thank you. Hello, and thank you for joining us. On today's call, we have David Enloe, President and CEO; and Ryan Lake, Chief Financial Officer.
Today, we'll be providing an overview of Recro's contract development and manufacturing business, including updates on corporate activities and financial results for the quarter and year ended December 31, 2021. After our prepared remarks, we will welcome your questions.
Before we begin, I'd like to caution that comments made during this conference call today, March 1, 2022, will contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, concerning
Q4 2021 Recro Pharma Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot